EAST - AFNET 4 an AFNET e.V. / EHRA Trial

EAST - AFNET 4
an AFNET e.V. / EHRA Trial

STUDY OBJECTIVE

The EAST trial is to test whether an early, comprehensive, rhythm control therapy can prevent adverse cardiovascular outcomes in patients with atrial fibrillation (AF) compared to usual care.

GermanyBelgiumCzech RepublicFranceGreat BritainItalyNetherlandsPolandSpainSwitzerlandDenmark

 

EAST is registered at ClinicalTrials.gov, ISRTCN, and EU Clinical Trials Register

ClinicalTrials.gov: NCT01288352
http://clinicaltrials.gov/ct2/show/NCT01288352?term=NCT01288352&rank=1

ISRCTN04708680
http://www.controlled-trials.com/ISRCTN04708680/ISRCTN04708680

EU Clinical Trials Register
https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2010-021258-20